skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma

Abstract

A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.

Inventors:
; ;
Issue Date:
Research Org.:
Univ. of Missouri, Columbia, MO (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1531460
Patent Number(s):
6607709
Application Number:
09/686,700
Assignee:
The Curators of the University of Missouri (Columbia, MO)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
DOE Contract Number:  
FG02-93ER61661
Resource Type:
Patent
Resource Relation:
Patent File Date: 2000-10-11
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE

Citation Formats

Jurisson, Silvia S., Quinn, Thomas P., and Giblin, Michael F. Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma. United States: N. p., 2003. Web.
Jurisson, Silvia S., Quinn, Thomas P., & Giblin, Michael F. Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma. United States.
Jurisson, Silvia S., Quinn, Thomas P., and Giblin, Michael F. Tue . "Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma". United States. https://www.osti.gov/servlets/purl/1531460.
@article{osti_1531460,
title = {Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma},
author = {Jurisson, Silvia S. and Quinn, Thomas P. and Giblin, Michael F.},
abstractNote = {A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2003},
month = {8}
}

Patent:

Save / Share: